Skip to main content

Published locations for Upadacitinib shows superior efficacy over dupilumab for moderate-to-severe atopic dermatitis in phase 3b

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Upadacitinib shows superior efficacy over dupilumab for moderate-to-severe atopic dermatitis in phase 3b

User login

  • Reset your password
  • /content/upadacitinib-shows-superior-efficacy-over-dupilumab-moderate-severe-atopic-dermatitis-phase
  • /dermatology/article/244701/atopic-dermatitis/upadacitinib-shows-superior-efficacy-over-dupilumab